LINC01884

Across TCGA pan-cancer cohorts, LINC01884 RNA is linked to patient survival in 9 of 34 cancer types, making it the most broadly survival-associated LINC01884 data layer.

The strongest signal is observed in breast invasive carcinoma (BRCA), where higher LINC01884 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated LINC01884 expression acts as an unfavorable survival marker, although some lineages such as ESCA show a favorable association.

BRCA, PAAD, and STAD are the cancer types where LINC01884 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
BRCA	OS	Tertile	All	0.592	0.925	<.001	96	view →
PAAD	OS	Tertile	All	0.107	0.640	<.001	72	view →
STAD	DFS	Tertile	All	0.258	0.564	<.001	54	view →
ESCA	DFS	Tertile	II,III,IV	1.000	0.290	.030	45	view →
SKCM	OS	Tertile	All	0.359	0.785	<.001	45	view →
LIHC	OS	Tertile	All	0.105	0.777	<.001	27	view →
OV	OS	Tertile	III,IV	0.410	0.683	.041	18	view →
BLCA	DFS	Tertile	III,IV	0.159	0.572	.036	9	view →
SARC	DFS	Tertile	All	0.096	0.591	.006	9	view →

Pink = unfavorable, green = favorable. Showing the 9 strongest of 9 lineages.

LINC01884–BRCA (OS)

Open the BRCA breakdown →